Checkpoint Capital’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-174,769
| Closed | -$14.8M | – | 16 |
|
|
2024
Q4 | $14.8M | Sell |
174,769
-34,863
| -17% | -$2.95M | 7.53% | 4 |
|
|
2024
Q3 | $18.8M | Sell |
209,632
-81,140
| -28% | -$7.29M | 9.35% | 5 |
|
|
2024
Q2 | $23.4M | Buy |
290,772
+158,335
| +120% | +$12.7M | 14.11% | 3 |
|
|
2024
Q1 | $10.6M | Sell |
132,437
-22,909
| -15% | -$1.83M | 7.06% | 5 |
|
|
2023
Q4 | $12.4M | Buy |
+155,346
| New | +$12.4M | 7.49% | 5 |
|